Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC therapy in de novo acute GVHD
NCT01589549Phase 2Unknown
- Sponsor
- R.P. Herrmann
- Start
- Apr 2012
- Primary completion
- Dec 2015
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Provacel in graft-versus-host disease (GVHD), sponsored by R.P. Herrmann. Status: unknown.
02
Drugs
Provacel
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01589549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01589549.